CD68 and melanoma: These findings were most likely due to a heterotypic fusion of melanoma cells with other cells, as these BRAFV600E mutations were present in peritumoral Melanoma Antigen Recognized by T cells (MART1)+/smooth muscle antigen (SMA)+ fibroblasts and MART1+/CD68+ macrophages [39].